Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 57-64

  Stannard, Anita K ^a   Riddell, David R ^a   Bradley, Nicholas J ^a   Hassall, David G ^b   Graham, Annette ^a   Owen, James S ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Atherosclerosis; Cell adhesion molecules; Flow cytometry; Human umbilical vein endothelial cells; Inflammatory cytokines

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; ESTRADIOL; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032127015     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00052-5     Document Type: Article

References (40)

1. Imhof B.A., Dunon D. Leukocyte migration and adhesion. Adv Immunol. 58:1995;345-416.
2. Van der Wal A.C., Das P.K., Tigges A.J., Becker A.E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 141:1992;1427-1433.
3. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., McCarty J., Ferguson M., Hudkins K., Benjamin C.D., Lobb R., Alpers C.E. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 92:1993;945-951.
4. Johnson-Tidey R.R., McGregor J.L., Tayor P.R., Poston R.N. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques: Coexpression with intercellular adhesion molecule-1. Am J Pathol. 144:1994;952-961.
5. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
6. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowsky S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
7. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
8. Fazio S., Lee Y.-L., Ji Z.-S., Rall S.C. Jr. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest. 92:1993;1497-1503.
9. Linton M.F., Atkinson J.B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1995;1034-1037.
10. Yamada N., Inoue I., Kawamura M., Harada K., Watanabe Y., Shimano H., Gotoda T., Shimada M., Kohzaki K., Tsukada T., Shiomi M., Watanabe Y., Yazaki Y. Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. J Clin Invest. 89:1992;706-711.
11. Shimano H., Ohsuga J., Shimada M., Namba Y., Gotoda T., Harada K., Katsuki M., Yazaki Y., Yamada N. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest. 95:1995;469-476.
12. O'Brien K.D., Deeb S.S., Ferguson M., McDonald T.O., Allen M.D., Alpers C.E., Chait A. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol. 144:1994;538-548.
13. Rosenfeld M.E., Butler S., Ord V.A., Lipton B.A., Dyer C.A., Curtiss L.K., Palinski W., Witztum J.L. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb. 13:1993;1382-1389.
14. Basu S.K., Ho Y.K., Brown M.S., Bilheimer D.W., Anderson R.G.W., Goldstein J.L. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem. 257:1982;9788-9795.
15. Breslow J.L. Mouse models of atherosclerosis. Science. 272:1996;685-693.
16. Mazzone T. Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol. 7:1996;303-307.
17. Stevenson S.C., Marshall-Neff J., Teng B., Lee C.B., Roy S., McClelland A. Phenotypic correction of hypercholesterolemia in apo E-deficient mice by adenovirus-mediated in vivo gene transfer. Arterioscler Thromb Vasc Biol. 15:1995;479-484.
18. Kashyap V.S., Santamarina-Fojo S., Brown D.R., Parrott C.L., Applebaum-Bowden D., Meyn S., Talley G., Paigen B., Maeda N., Brewer H.B. Jr. Apolipoprotein E deficiency in mice: Gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest. 96:1995;1612-1620.
19. Boisvert W.A., Spangenberg J., Curtiss L.K. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest. 96:1995;1118-1124.
20. Bellosta S., Mahley R.W., Sanan D.A., Murata J., Newland D.L., Taylor J.M., Pitas R.E. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest. 96:1995;2170-2179.
21. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A., Greaves M.F. Expression of the CD34 gene in vascular endothelial cells. Blood. 75:1990;2417-2426.
22. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52:1973;2745-2756.
23. Innerarity T.L., Pitas R.E., Mahley R.W. Lipoprotein-receptor interactions. Methods Enzymol. 129:1986;542-565.
24. Innerarity T.L., Pitas R.E., Mahley R.W. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem. 254:1979;4186-4190.
25. Riddell D.R., Graham A., Owen J.S. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. J Biol Chem. 272:1997;89-95.
26. De Caterina R., Libby P., Peng H.-B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
27. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule-1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 93:1996;9114-9119.
28. Nakai K., Itoh C., Hotta K., Itoh T., Yoshizumi M., Hiramori K. Estradiol-17β regulates the induction of VCAM-1 mRNA expression by interleukin-1β in human umbilical vein endothelial cells. Life Sci. 54:1994;221-227.
29. Caulin-Glaser T., Watson C.A., Pardi R., Bender J.R. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 98:1996;36-42.
30. Saxena U., Goldberg I.J. Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr Opin Lipidol. 5:1994;316-322.
31. Vogel T., Guo N., Guy R., Drezlich N., Krutzsch H.C., Blake D.A., Panet A., Roberts D.D. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 54:1994;299-308.
32. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Genet. 14:1996;55-61.
33. Riddell D.R., Vinogradov D.V., Chadwick N.C., Stannard A.K., Owen J.S. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway - Initial characterisation of the platelet receptor. FASEB J. 11:1997;A1431.
34. Russell P.S., Chase C.M., Colvin R.B. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol. 149:1996;91-99.
35. Klein C.L., Kohler H., Bittinger F., Wagner M., Hermanns I., Grant K., Lewis J.C., Kirkpatrick C.J. Comparative studies on vascular endothelium in vitro. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cells. Pathobiology. 62:1994;199-208.
36. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 65:1990;297-302.
37. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
38. Scholz D., Devaux B., Hirche A., Potzsch B., Kropp B., Schaper W., Schaper J. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res. 284:1996;415-423.
39. Kauser K., Rubanyi G.M. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxde production by estrogen. J Vasc Res. 34:1997;229-236.
40. Van Lenten B.J., Hama S.Y., de Beer F.C., Stafforini D.M., McIntyre T.M., Prescott S.M., La Du B.N., Fogelman A.M., Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 96:1995;2758-2767.